PSA test use in general practice

This trial studies whether a targeted scan (PSMA PET/CT) can help doctors choose the best “salvage” radiation treatment when prostate cancer comes back by PSA blood tests after surgery. It may help some people avoid under- or over-treating the areas where the cancer is returning.

This study tests a health education program to help men learn about prostate cancer and encourage them to get screened. It is a pilot study that will see if the program works, so it might help you understand your risk and take action for your health.

This trial tests whether an alert in your electronic health record helps more people get PSA screening for prostate cancer. If you are a man at average or high risk, this study may help ensure you are screened appropriately.

This trial studies a treatment that targets a protein called PSMA in people with prostate cancer. It may help shrink or control the cancer and is being tested in different risk groups and stages of disease.

This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.

This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.